In vitro delivery of novel, highly potent anti-varicella Zoster virus nucleoside analogues to their target site in the skin

Pharmaceutical Research

Volumn 21, Issue 6, 2004, Pages 914-919

  Jarvis, Chris A ^a   McGuigan, Chris ^a   Heard, Charles M ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

antiviral; herpesvirus; PHN; shingles; topical; zoster

Indexed keywords

ACICLOVIR; CF 1698; CF 1712; CF 1743; NUCLEOSIDE ANALOG; PROPYLENE GLYCOL; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CELL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CREAM; DERMATOME; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG PENETRATION; DRUG POTENCY; DRUG SELECTIVITY; DRUG TARGETING; EPIDERMIS; IN VITRO STUDY; LIPOPHILICITY; MEMBRANE; NONHUMAN; PRIORITY JOURNAL; SAMPLE; SEPARATION TECHNIQUE; SKIN; SKIN PERMEABILITY; SKINFOLD THICKNESS; SUPERINFECTION; SWINE; TIME; VARICELLA ZOSTER VIRUS; VIRUS LOAD; VIRUS REPLICATION;

ACYCLOVIR; ADMINISTRATION, CUTANEOUS; ANIMALS; ANTIVIRAL AGENTS; CHEMISTRY, PHARMACEUTICAL; DRUG DELIVERY SYSTEMS; GREAT BRITAIN; HERPESVIRUS 3, HUMAN; NUCLEOSIDES; OINTMENTS; PERMEABILITY; PHARMACEUTICAL SOLUTIONS; PYRIMIDINE NUCLEOSIDES; SKIN; SKIN ABSORPTION; SUSPENSIONS; SWINE;

EID: 3042809970     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:PHAM.0000029277.60760.43     Document Type: Article

References (23)

1. A. M. Arvin. Varicella-zoster virus: molecular virology and virus-host interactions. Curr. Opin. Microbiol. 4:442-9 (2001).
2. R. E. Hope-Simpson. The nature of herpes zoster: A long-term study and a new hypothesis. Proc. Royal. Soc. Med. 58:9-20 (1965).
3. G. E. Kanazi, R. W. Johnson, and R. H. Dworkin. Treatment of postherpetic neuralgia - An update. Drugs 59:1113-1126 (2000).
4. B. V. MacFarlane, A. Wright, J. O. O'Callaghan, and H. A. E. Benson. Chronic neuropathic pain and its control by drugs. Pharm. Therap. 75:1-19 (1997).
5. A. Abendroth and A. M. Arvin. Immune evasion as a pathogenic mechanism of varicella zoster virus. Sem. Immun. 13:27-39 (2001).
6. J. P. Quinn, R. G. Dalziel, and A. A. Nash. Herpes virus latency in sensory ganglia - a comparison with endogenous neuronal gene expression. Prog. Neurobiol. 60:167-79 (2000).
7. Y. Lim, S. Chang, J. Choi, K. Sung, J. Bahk, S. Do, and D. Lee. Expression of inducible nitric oxide synthase in skin lesions of acute herpes zoster. J. Dermatol Sci. 29:201-205 (2002).
8. A. L. Oaklander. The density of remaining nerve endings in human skin with and without postherpetic neuralgia after shingles. Pain 92:139-145 (2001).
9. G. E. Parry, P. Dunn, V. P. Shah, and L. K. Pershing. Acyclovir bioavailability in human skin. J. Invest. Dermatol. 98:856-63 (1992).
10. R. H. Dworkin and R. K. Portenoy. Pain and its persistence in herpes zoster. Pain 67:241-251 (1996).
11. C. McGuigan, H. Barucki, S. Blewett, A. Carangio, J. T. Erichsen, G. Andrei, R. Snoeck, E. De Clercq, and J. Balzarini. Highly potent and selective inhibition of varicella-zoster virus by bicyclic furopyrimidine nucleosides bearing an aryl side chain. J. Med. Chem. 43:4993-4997 (2000).
12. G. A. Simon and H. I. Maibach. The pig as an experimental animal model of percutaneous permeation in man: qualitative and quantitative observations - an overview. Skin Pharmacol. Appl. Skin Physiol. 13:229-34 (2000).
13. F. P. Schmook, J. G. Meingassner, and A. Billich. Comparison of human skin or epidermis models with human and animal skin in in-vitro percutaneous absorption. Int. J. Pharm. 215:51-6 (2001).
14. M. A. Pellett, M. S. Roberts, and J. Hadgraft. Supersaturated solutions evaluated with an in vitro stratum corneum tape stripping technique. Int. J. Pharm. 151:91-98 (1997).
15. K. Moser, K. Kriwet, A. Naik, Y. N. Kalia, and R. H. Guy, Passive skin penetration enhancement and its quantification in vitro. Eur. J. Pharm. Biopharm. 52:103-12 (2001).
16. K. Xu, M. Lanuti, E. S. Lambright, S. D. Force, S. M. Albelda, and I. A. Blair. A rapid and sensitive method for the quantification of ganciclovir in plasma using liquid chromatography/selected reaction monitoring/mass spectrometry. Biomed. Chromatogr. 14:93-8 (2000).
17. G. K. Menon and P. M. Elias. Morphologic basis for a porepathway in mammalian stratum corneum. Skin Pharmacology 10:235-246 (1997).
18. M. Sznitowska, B. Berner, and H. I. Maibach. Percutaneous Penetration of Multipolar Ions - Evidence for Porous Transport. Int. J. Pharm. 123:41-45 (1995).
19. M. Sznitowska, S. Janicki, and A. C. Williams. Intracellular or intercellular localization of the polar pathway of penetration across stratum corneum. J. Pharm. Sci. 87:1109-14 (1998).
20. H. Tang, D. Blankschtein, and R. Langer. Prediction of steady-state skin permeabilities of polar and nonpolar permeants across excised pig skin based on measurements of transient diffusion: characterization of hydration effects on the skin porous pathway. J. Pharm. Sci. 91:1891-907 (2002).
21. W. Meyer and N. H. Zschemisch. Skin layer thickness at the ear of the domesticated pig, with special reference to the use of porcine ear integument for human dermatological research. Berliner Und Munchener Tierarztliche Wochenschrift 115:401-406 (2002).
22. H. Head and A. W. Campbell. The pathology of herpes zoster and its bearing on sensory localisation. Brain 23:353-523 (1900).
23. M. C. Rowbotham and K. L. Petersen. Zoster-associated pain and neural dysfunction. Pain 93:1-5 (2001).